发明申请
- 专利标题： Albumin fusion proteins
- 专利标题（中）： 白蛋白融合蛋白
-
申请号： US11078663申请日： 2005-03-14
-
公开(公告)号： US20050266532A1公开(公告)日： 2005-12-01
- 发明人: Craig Rosen , Homayoun Sadeghi , Christopher Prior , Andrew Turner
- 申请人： Craig Rosen , Homayoun Sadeghi , Christopher Prior , Andrew Turner
- 专利权人： Human Genome Sciences, Inc.,Principia Pharmaceutical Corporation
- 当前专利权人： Human Genome Sciences, Inc.,Principia Pharmaceutical Corporation
- 主分类号： C12N15/09
- IPC分类号： C12N15/09 ; A61K35/12 ; A61K35/76 ; A61K38/00 ; A61K38/21 ; A61K38/22 ; A61K38/23 ; A61K38/27 ; A61K38/28 ; A61K38/43 ; A61K38/46 ; A61K38/48 ; A61K38/55 ; A61K39/00 ; A61K39/395 ; A61K47/48 ; A61K48/00 ; A61P1/00 ; A61P1/04 ; A61P1/16 ; A61P1/18 ; A61P3/10 ; A61P3/14 ; A61P5/00 ; A61P5/10 ; A61P5/14 ; A61P5/40 ; A61P7/00 ; A61P7/04 ; A61P7/06 ; A61P9/00 ; A61P9/06 ; A61P9/10 ; A61P9/12 ; A61P11/00 ; A61P11/06 ; A61P13/00 ; A61P13/02 ; A61P13/08 ; A61P13/12 ; A61P15/00 ; A61P15/08 ; A61P15/10 ; A61P15/18 ; A61P17/00 ; A61P17/02 ; A61P17/06 ; A61P17/12 ; A61P17/14 ; A61P19/00 ; A61P19/02 ; A61P19/08 ; A61P19/10 ; A61P21/00 ; A61P21/04 ; A61P25/00 ; A61P25/02 ; A61P25/08 ; A61P25/16 ; A61P25/28 ; A61P27/02 ; A61P29/00 ; A61P31/00 ; A61P31/12 ; A61P31/14 ; A61P31/16 ; A61P31/18 ; A61P31/20 ; A61P31/22 ; A61P33/02 ; A61P33/06 ; A61P33/12 ; A61P35/00 ; A61P35/02 ; A61P35/04 ; A61P37/00 ; A61P37/02 ; A61P37/04 ; A61P37/06 ; A61P37/08 ; A61P39/02 ; A61P41/00 ; A61P43/00 ; C07K14/47 ; C07K14/55 ; C07K14/56 ; C07K14/565 ; C07K14/585 ; C07K14/60 ; C07K14/61 ; C07K14/62 ; C07K14/635 ; C07K14/65 ; C07K14/705 ; C07K14/715 ; C07K14/745 ; C07K14/75 ; C07K14/76 ; C07K14/765 ; C07K14/81 ; C07K16/00 ; C07K19/00 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N5/02 ; C12N5/10 ; C12N9/14 ; C12N9/74 ; C12N9/99 ; C12N15/62 ; A61K38/17 ; C07H21/04 ; C12P21/04
摘要：
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
公开/授权文献
- US07507414B2 Albumin fusion proteins 公开/授权日：2009-03-24
信息查询
IPC分类:
